LADENBURG THALM/SH SH initiated coverage on shares of Jaguar Health (NASDAQ:JAGX) in a research note published on Thursday morning, The Fly reports. The brokerage issued a buy rating and a $5.00 price target on the biotechnology company’s stock.
Several other brokerages also recently commented on JAGX. ValuEngine raised shares of Jaguar Health from a hold rating to a buy rating in a research report on Thursday, August 1st. Zacks Investment Research downgraded shares of Jaguar Health from a buy rating to a hold rating in a research report on Thursday, August 15th. Finally, HC Wainwright set a $10.00 price objective on shares of Jaguar Health and gave the stock a buy rating in a research report on Tuesday, July 2nd.
Shares of JAGX stock opened at $1.33 on Thursday. The company has a market cap of $61.66 million, a price-to-earnings ratio of -0.01 and a beta of 0.74. Jaguar Health has a 52 week low of $1.00 and a 52 week high of $175.00. The company has a quick ratio of 0.24, a current ratio of 0.35 and a debt-to-equity ratio of 0.02. The firm has a 50 day moving average of $1.35 and a 200-day moving average of $1.54.
In other Jaguar Health news, Director James J. Bochnowski purchased 180,582 shares of Jaguar Health stock in a transaction that occurred on Tuesday, July 23rd. The stock was acquired at an average price of $2.00 per share, with a total value of $361,164.00. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.81% of the company’s stock.
About Jaguar Health
Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
Read More: Cash Asset Ratio
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.